Trillium Therapeutics Inc (TRIL)

[Inoviorulez]

TRIL has until March 20, 2020 to get 10 consecutive days above $1. It is already trading at .94 to .97 range. Just on speculation alone it will run past $1. But even then setting that aside, there are 3 avenues it could rise:

1.) Positive update on one of the anti-CD47 products in pipeline

2.) Second-generation sting agonist partnership with big pharma, this product has shown anti-tumor activity both as intravenous infusion and oral pill form

3,) Partnership on one of the 3 anti-CD47 products.

In other words, it will be easy to meet compliance. Matter of fact, I believe that it is not even an issue.